RenewalBio Project Introduction, Team, Financing and News

Performances

RD Popularity Index

23155.56% (24h)

0100200300400500

Project Rank: 10329/15393

RD Growth Index

1570.77% (24h)

0400800120016002000

Project Rank: 3583/15393

Comparison

Team

Vladik Krupalnik

CEO , Co-Founder and Board member

Ohad Gafni

Co-Founder & CSO

Fundraising

YYZi Labs

Round	Amount	Valuation	Date	Source	Investor
--	--	--	Nov 11, 2025		YYZi Labs

Details

RenewalBio is a biotechnology company focused on regenerative medicine. It utilizes its proprietary Stembroid™ platform to reprogram adult cells into induced pluripotent stem cells and guide their differentiation in a three-dimensional environment mimicking early embryonic development, generating transplantable cells and tissues matched to the patient's DNA. The technology aims to address the shortage of organ donors and immune rejection. Current efforts focus on developing hematopoietic stem cells for leukemia and immune disorders, with exploration into liver, heart, and pancreatic cell applications. The company is in the R&D stage, with participation limited to research collaborations and institutional partnerships.

Tags:

Medical health

Founded:

2022

Location:

Israel

Rate RenewalBio

0.0

Rated by 0 users

What’s your take on RenewalBio? Share your review.

Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.